STERIS plc
STE
NYSE·Healthcare·Medical - Specialties·Mkt cap $22.1B
$226.83
▼ -1.53%
P/E
29.31
Mkt Cap
$22.1B
52-Wk Range
$195.14–$269.44
52-Week Range
$195.14 - $269.44
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 6.8% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Global sterilization facility network
- Comprehensive infection prevention portfolio
- Advanced medical equipment engineering
- Extensive healthcare industry experience
Bear Case
1 risk
- Average volatility.
Growth
Stable outlook
Increasing healthcare infection control standards
Value
Fairly valued vs Medical Devices peers
Momentum
Strong
+6.9% over 3m
Quality
Strong
Excellent business quality
Dividend
Modest
1.11% yield
Smart-money signal
Who's buying STE right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
AUG 5, 2026
Reported EPS of $2.59 vs $2.49 consensus (+4.0% surprise). Revenue of $1.5B vs $1.5B expected (+0.3%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+4.0%
Revenue trend · last 8Q
—
—
+6%
+33%
+9%
+10%
+9%
+7%
Q1 24
Q2 24
Q3 24
Q4 25
Q1 25
Q2 25
Q3 25
Q1 27
$1.3B
$1.3B
$1.4B
$1.5B
$1.4B
$1.5B
$1.5B
$1.5B
Margins · last 8Q
Gross
45.8%
Operating
19.1%
Profit
13.4%
Wall Street consensus
2 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: UBS · Jul 28, 2026
vs Industry
How STE stacks vs Medical - Specialties
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related